Who are Orasis Pharmaceuticals's investors?

Orasis Pharmaceuticals's investors include Arboretum Ventures, Maverick Ventures Israel, Visionary Ventures, Catalio Capital Management, Johnson & Johnson Innovation – JJDC, LifeSci Venture Partners, Sequoia Capital, Catalio Capital Management, LP.

Orasis Pharmaceuticals

Founded 2015 · 68 employees on LinkedIn · 11 known investors

Find your way into Orasis Pharmaceuticals

Paths you didn't know you had: your email and LinkedIn already hold routes to the Orasis Pharmaceuticals team. We find them
2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Orasis is a pharmaceutical company developing drugs for the eye, operating in the ophthalmology and eyecare space. It is backed by healthcare-focused investors and announced a Series D financing in October 2024.

Biotech Healthtech Medical Devices

Investors · 11

Arboretum Ventures✓ confirmed by Orasis PharmaceuticalsAnn Arbor · $5M – $15M

How we know: Arboretum Ventures's portfolio page · the company's own site · the VCSheet dataset · Not right? Tell us

Maverick Ventures Israel✓ confirmed by Orasis PharmaceuticalsTel Aviv · $2M – $5M

How we know: Maverick Ventures Israel's portfolio page · the company's own site · healio.com · Not right? Tell us

Visionary Ventures✓ confirmed by Orasis PharmaceuticalsNewport Beach · $5M – $15M

How we know: the company's own site · funding news · orasis-pharma.com · Not right? Tell us

Catalio Capital Management✓ confirmed by Orasis PharmaceuticalsNew York

How we know: the company's own site · funding news · Not right? Tell us

Johnson & Johnson Innovation – JJDC✓ confirmed by Orasis PharmaceuticalsNew Brunswick

How we know: the company's own site · Not right? Tell us

LifeSci Venture Partners✓ confirmed by Orasis PharmaceuticalsNew York

How we know: the company's own site · orasis-pharma.com · Not right? Tell us

Sequoia Capital✓ confirmed by Orasis PharmaceuticalsMenlo Park · $100K – $50M

How we know: the company's own site · funding news · orasis-pharma.com · Not right? Tell us

Catalio Capital Management, LPlisted by Catalio Capital Management, LPNew York

How we know: Catalio Capital Management, LP's portfolio page · Not right? Tell us

Also in the syndicate · 3

Bluestem CapitalleadSBI (Japan) Innovation FundSBI (Japan) Innovation Ventures

Funding

SEC filings, press & company announcements

Undisclosed amountSeries CSep 2020
Bluestem Capital (lead), Visionary Ventures (lead), LifeSci Venture Partners, Maverick Ventures Israel, SBI (Japan) Innovation Fund, Sequoia Capital
Source ↗
Undisclosed amountSeries BJun 2018
Visionary Ventures (lead), LifeSci Venture Partners, SBI (Japan) Innovation Ventures, Sequoia Capital
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Orasis Pharmaceuticals Completes $78 Million Financing to Support Commercial Launch of Qlosi™ (pilocarpine hydrochloride ophthalmic solution) 0.4% - Orasisorasis-pharma.com · Oct 2024

Orasis Raises $30 Million to Advance the Clinical Development of Novel Treatment for Presbyopia - Orasisorasis-pharma.com · Sep 2020

Orasis Pharmaceuticals Closes $13 Million Series B Financingorasis-pharma.com · Jun 2018

Frequently asked questions

What does Orasis Pharmaceuticals do?: Orasis is a pharmaceutical company developing drugs for the eye, operating in the ophthalmology and eyecare space. It is backed by healthcare-focused investors and announced a Series D financing in October 2024.
Who are Orasis Pharmaceuticals's investors?: Orasis Pharmaceuticals's investors include Arboretum Ventures, Maverick Ventures Israel, Visionary Ventures, Catalio Capital Management, Johnson & Johnson Innovation – JJDC, LifeSci Venture Partners, Sequoia Capital, Catalio Capital Management, LP.